ArticleAIDS and behavior2026
Sexual Behaviour, HIV Prevention and Testing Among Transgender and Non-binary People in a Cross-Sectional Behavioural Surveillance Survey in Aotearoa New Zealand.
Article in AIDS and behavior, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Trans and non-binary (TNB) people who have sex with gay, bisexual and other men who have sex with men (GBM) are rarely included in HIV behavioural surveillance. Improved data on risk and protective behaviours among TNB people could help identify unmet needs. We analysed data from the Sex and Prevention of Transmission Study, a cross-sectional HIV behavioural surveillance programme in Aotearoa New Zealand that extended eligibility to TNB participants for the first time in 2022. We categorised TNB participants who reported sex with GBM < 5 years into four groups: trans women (TW), trans men (TM), non-binary people assigned male at birth (AMAB), non-binary people assigned female at birth (AFAB). TNB participants were younger, more socioeconomically disadvantaged, and reported more long‑term disability than cis GBM. Compared to cis GBM, TM and non-binary AFAB participants reported fewer male partners and more sex with women and non‑binary partners, whereas TW and non-binary AMAB participants' partnering more closely resembled cis GBM. HIV testing < 12 months was lower across all TNB groups, and PrEP < 6 months was lower among TM and non-binary AFAB participants. Sexually transmitted infection screening and diagnosis < 12 months appeared similar across all participants; few TNB participants reported living with HIV. TNB participants reported higher levels of negative healthcare experiences and injecting drug use, but not methamphetamine use. Each TNB subpopulation had a unique behavioural profile that differed from both other TNB participants and cis GBM. Lower uptake of HIV testing and PrEP could reflect less risk exposure, service barriers, or both.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.